An investigation into the role of coagulation factor XIII in ADP-induced aggregation and fibrinogen binding with rabbit platelets.
Because there was a possibility that activated factor XIII (factor XIIIa) might stabilize a platelet-fibrinogen aggregate through its crosslinking action, we have isolated plasma factor XIII, activated it, and studied the effect of factor XIIIa at a concentration of 3.3 micrograms/ml on aggregation and 125I-fibrinogen binding of rabbit platelets stimulated with 9 microM ADP. Factor XIIIa did not cause aggregation in the absence of ADP, nor did it enhance ADP-induced aggregation or substantially stabilize the platelet aggregate. The presence of factor XIIIa did not affect the amount of fibrinogen bound to platelets immediately after stimulation with ADP, but it appeared to cause a slow specific binding of 125I-fibrinogen to platelets whether or not they were stimulated with ADP. This binding, which was not inhibited by prostaglandin E1, did not lead to aggregation and was accompanied by crosslinking of fibrinogen through its A alpha and gamma chains, either to other fibrinogen molecules or to a platelet protein or proteins.
D000244:Adenosine Diphosphate / Q000494:pharmacology*; D000818:Animals; D000990:Antithrombin III / Q000494:pharmacology; D001081:Apyrase / Q000494:pharmacology; D003402:Creatine Kinase / Q000494:pharmacology; D005176:Factor XIII / Q000502:physiology*; D005340:Fibrinogen / Q000378:metabolism*; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D010725:Phosphocreatine / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011485:Protein Binding / Q000187:drug effects*; D011817:Rabbits
D010725:Phosphocreatine; D000244:Adenosine Diphosphate; D000990:Antithrombin III; D005340:Fibrinogen; D006493:Heparin; D005176:Factor XIII; D003402:Creatine Kinase; D001081:Apyrase